UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): May 4, 2015

                                 AMERICANN, INC.
                   ------------------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                      000-54231                27-4336843
  ------------------------         ----------------           ----------------
(State or other jurisdiction     (Commission File No.)      (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                 ----------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000


          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement  communications  pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 1.01.  Entry Into a Material Definitive Agreement

Monaco Property

     On July 31, 2014 the Company  closed on an all cash purchase of a five-acre
parcel of land located in north central  Denver,  Colorado.  The total  purchase
price the  Company  paid for the  property  was  $2,250,000.  On May 4, 2015 the
Company  entered into an  agreement  to sell the  property for a total  purchase
price of  $2,500,000.  The  closing  of the  transaction  is to take place on or
before July 3, 2015.

Freetown Agreement

     On January 14,  2015,  the Company  entered into an agreement to purchase a
52.6 acre parcel of undeveloped land in Freetown, Massachusetts. The property is
located approximately 47 miles southeast of Boston. The Company plans to develop
the property as the Massachusetts  Medical Cannabis Center "MMCC". Plans for the
MMCC  may  include  the  construction  of  sustainable  greenhouse  cultivation,
processing,  and  infused  product  facilities  that  will be  leased or sold to
Registered  Marijuana  Dispensaries  under the  Massachusetts  Medical Marijuana
Program.  Additional  plans for the MMCC may  include a  testing  laboratory,  a
research facility, a training center and corporate offices.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing.  Pursuant to the original agreement the closing was to take place on or
before  June 1, 2015.  On May 6, 2015 the  agreement  was  amended to extend the
closing date to September 1, 2015.

      The Company does not cultivate, process or sell cannabis.

Item 9.01.  Financial Statements and Exhibits

Exhibit Number          Description

    10.2                Contract to Buy and Sell Real Estate (to be filed as an
                        exhibit to the Company's 10-Q report for the period
                        ending June 30, 2015).

    10.3                Third Amendment to Purchase and Sale Agreement.

                                       2
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: May 12, 2015
                                      AMERICANN, INC.


                                      By: /s/ Timothy Keogh
                                          --------------------------------------
                                          Timothy Keogh, Chief Executive Officer



                                       3
[{"type": "8-K", "sequence": "1", "filename": "form8kitem101may-15.txt", "description": "8-K RE MONACO PROP. & FREEPORT AGREE.", "secsgml_size_bytes": 4544}]
{"company-data": {"conformed-name": "AmeriCann, Inc.", "cik": "0001508348", "assigned-sic": "6770", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "15858256"}, "business-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216", "phone": "303-898-9832"}, "mail-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216"}, "former-company": [{"former-conformed-name": "Americann, Inc.", "date-changed": "20140516"}, {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

         Date of Report (date of earliest event reported): May 4, 2015

                                 AMERICANN, INC.
                   ------------------------------------------
             (Exact name of registrant as specified in its charter)

        Delaware                      000-54231                27-4336843
  ------------------------         ----------------           ----------------
(State or other jurisdiction     (Commission File No.)      (IRS Employer
  of incorporation)                                          Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                 ----------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000

          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement  communications  pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))
Item 1.01.  Entry Into a Material Definitive Agreement

Monaco Property

     On July 31, 2014 the Company  closed on an all cash purchase of a five-acre
parcel of land located in north central  Denver,  Colorado.  The total  purchase
price the  Company  paid for the  property  was  $2,250,000.  On May 4, 2015 the
Company  entered into an  agreement  to sell the  property for a total  purchase
price of  $2,500,000.  The  closing  of the  transaction  is to take place on or
before July 3, 2015.

Freetown Agreement

     On January 14,  2015,  the Company  entered into an agreement to purchase a
52.6 acre parcel of undeveloped land in Freetown, Massachusetts. The property is
located approximately 47 miles southeast of Boston. The Company plans to develop
the property as the Massachusetts  Medical Cannabis Center "MMCC". Plans for the
MMCC  may  include  the  construction  of  sustainable  greenhouse  cultivation,
processing,  and  infused  product  facilities  that  will be  leased or sold to
Registered  Marijuana  Dispensaries  under the  Massachusetts  Medical Marijuana
Program.  Additional  plans for the MMCC may  include a  testing  laboratory,  a
research facility, a training center and corporate offices.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing.  Pursuant to the original agreement the closing was to take place on or
before  June 1, 2015.  On May 6, 2015 the  agreement  was  amended to extend the
closing date to September 1, 2015.

      The Company does not cultivate, process or sell cannabis.

Item 9.01.  Financial Statements and Exhibits

Exhibit Number          Description

    10.2                Contract to Buy and Sell Real Estate (to be filed as an
                        exhibit to the Company's 10-Q report for the period
                        ending June 30, 2015).

    10.3                Third Amendment to Purchase and Sale Agreement.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: May 12, 2015
                                      AMERICANN, INC.

                                      By: /s/ Timothy Keogh
                                          --------------------------------------
                                          Timothy Keogh, Chief Executive Officer

                                       3